Panbela Therapeutics Inc
NASDAQ:PBLA

Watchlist Manager
Panbela Therapeutics Inc Logo
Panbela Therapeutics Inc
NASDAQ:PBLA
Watchlist
Price: 0.4401 USD -8.31% Market Closed
Updated: May 19, 2024

Panbela Therapeutics Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Panbela Therapeutics Inc
EPS (Diluted) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Panbela Therapeutics Inc
NASDAQ:PBLA
EPS (Diluted)
-$232
CAGR 3-Years
21%
CAGR 5-Years
31%
CAGR 10-Years
18%
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$3
CAGR 3-Years
6%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$0
CAGR 3-Years
18%
CAGR 5-Years
-39%
CAGR 10-Years
-18%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$7
CAGR 3-Years
-17%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
$15
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$33
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
25%

See Also

What is Panbela Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-232.4 USD

Based on the financial report for Dec 31, 2023, Panbela Therapeutics Inc's EPS (Diluted) amounts to -232.4 USD.

What is Panbela Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
18%

Over the last year, the EPS (Diluted) growth was 87%. The average annual EPS (Diluted) growth rates for Panbela Therapeutics Inc have been 21% over the past three years , 31% over the past five years , and 18% over the past ten years .